EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 3.0

Nitrogen-containing FDA-approved drugs in 2025: synthesis, significance and therapeutic applications

Chetna Jadala, Shweta Mishra, Gal Reddy Potuganti iD, Savio Cardoza, Ganga Reddy Velma iD

RSC Advances · 2026 · 16 (24) · 21967-22005

DOI: 10.1039/d6ra00737f ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift RSC Advances, 2026. Verfasst von Chetna Jadala und 4 weiteren Autor:innen. Beteiligte Einrichtung: Indiana University School of Medicine, Indiana University (IU) Indianapolis 46202 IN USA. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 137 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nitrogen-containing heterocycles (N-Hets) are among the most prevalent and versatile structural motifs in pharmaceuticals, serving as key scaffolds in over 85% of biologically active small molecules.

Autor:innen und Institutionen

  • Indiana University School of Medicine, Indiana University (IU) Indianapolis 46202 IN USA.
  • Dr. D.Y. Patil Institute of Pharmaceutical Sciences and Research Sant Tukaram Nagar, Pimpri Pune 411018 India.
  • DPGU - School of Pharmacy and Research Sant Tukaram Nagar, Pimpri Pune 411018 India.
  • Department of Chemistry and Biochemistry, The University of Oklahoma Norman Oklahoma 73019 USA.
  • Department of Pharmacology and Toxicology, R. Ken Coit College of Pharmacy, University of Arizona Tucson 85721 AZ USA vgreddy@arizona.edu velmagangareddy47@gmail.com.

ORCID-Profile: Gal Reddy Potuganti, Ganga Reddy Velma

Zitieren

APA

Jadala, C., Mishra, S., Potuganti, G. R., Cardoza, S., & Velma, G. R. (2026). Nitrogen-containing FDA-approved drugs in 2025: synthesis, significance and therapeutic applications. RSC Advances, 16(24), 21967-22005. https://doi.org/10.1039/d6ra00737f

Vancouver

Jadala C, Mishra S, Potuganti GR, Cardoza S, Velma GR. Nitrogen-containing FDA-approved drugs in 2025: synthesis, significance and therapeutic applications. RSC Advances. 2026;16(24):21967-22005. doi:10.1039/d6ra00737f

BibTeX
@article{Jadala2026,
  author = {Jadala, Chetna and Mishra, Shweta and Potuganti, Gal Reddy and Cardoza, Savio and Velma, Ganga Reddy},
  title = {Nitrogen-containing FDA-approved drugs in 2025: synthesis, significance and therapeutic applications},
  journal = {RSC Advances},
  year = {2026},
  volume = {16},
  number = {24},
  pages = {21967--22005},
  doi = {10.1039/d6ra00737f}
}
Kostenlos starten →